Stay updated with breaking news from Strides Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Market is likely to be volatile in the event-packed week as the participants will focus on the Interim Budget, Federal Reserve interest rate decision and auto sales for January.
The promoter has raised ₹350 crore in debt from Modulus Alternatives to help with the buyout. The fund, borrowed at the promoter level, is being used to refinance the debt.
Global Ethosuximide Market Analysis (2019 - 2030)
In the largecap segment, 15 companies witnessed significant block deals which were worth Rs 5,729 crore, led by Kotak Mahindra Bank.
Gautam Shah says: “One has to be very stock specific in this market, but just ensure that you are in stocks which have high institutional interest because there is so much money coming into midcaps and smallcaps, Rs 8,000 crore every month, That will propel many of these stocks higher and they will get re-rated along the way.”